First experience of balloon-occluded retrograde transvenous obliterationof gastric varices
G. V. Manukyan,
S. L. Malov,
R. A. Musin,
S. B. Zhigalova,
V. M. Lebezev,
E. A. Kitsenko,
E. E. Fandeyev https://doi.org/10.16931/1995-5464.2022-2-58-64
Abstract
Ten patients with cirrhosis and portal hypertension successfully underwent balloon-occluded retrograde transvenous obliteration (BRTO) of gastric varices. As an example, the paper presents a clinical observation demonstrating the use of a BRTO endovascular procedure. A spontaneous functioning gastrorenal shunt was distinctly observed during multidetector computed tomography in a patient with Child-Pugh А cirrhosis of alimentary-toxic and viral etiology, as well as portal hypertension and associated gastric varices (Type 2, Grade 3) with frequent recurrent bleeding. The presence of a shunt with no indications for TIPS procedure, as well as the inexpediency of a shunt surgery (taking positive immunoblot into account), enabled the formulation of indications for BRTO. This factor ensured regression of gastric varices, as well as eliminated the threat of recurrent gastric bleeding.
About the Authors
G. V. Manukyan
Laboratory of Emergency Surgery and Portal Hypertension, Petrovsky National Research Center of Surgery
Russian Federation
Russian Federation
Garik V. Manukyan – Doct. of Sci. (Med.)
2, Abrikosovsky lane, Moscow, 119991
S. L. Malov
Laboratory of Emergency Surgery and Portal Hypertension, Petrovsky National Research Center of Surgery
Russian Federation
Russian Federation
Svyatoslav L. Malov – Specialist in X-ray endovascular diagnostics and treatment
2, Abrikosovsky lane, Moscow, 119991
R. A. Musin
Laboratory of Emergency Surgery and Portal Hypertension, Petrovsky National Research Center of Surgery
Russian Federation
Russian Federation
Rustam A. Musin – Cand. of Sci. (Med.)
2, Abrikosovsky lane, Moscow, 119991
S. B. Zhigalova
Laboratory of Emergency Surgery and Portal Hypertension, Petrovsky National Research Center of Surgery
Russian Federation
Russian Federation
Svetlana B. Zhigalova – Doct. of Sci. (Med.)
2, Abrikosovsky lane, Moscow, 119991
V. M. Lebezev
Laboratory of Emergency Surgery and Portal Hypertension, Petrovsky National Research Center of Surgery
Russian Federation
Russian Federation
Victor M. Lebezev – Doct. of Sci. (Med.)
2, Abrikosovsky lane, Moscow, 119991
E. A. Kitsenko
Laboratory of Emergency Surgery and Portal Hypertension, Petrovsky National Research Center of Surgery
Russian Federation
Russian Federation
Evgeny A. Kitsenko – Doct. of Sci. (Med.)
2, Abrikosovsky lane, Moscow, 119991
E. E. Fandeyev
Laboratory of Emergency Surgery and Portal Hypertension, Petrovsky National Research Center of Surgery
Russian Federation
Russian Federation
Evgeny E. Fandeyev – Cand. of Sci. (Med.), Senior Researcher
2, Abrikosovsky lane, Moscow, 119991
References
1. Khoronko Yu.V., Kosovtsev E.V., Kozyrevskiy M.A., Khoronko E.Yu., Krivotorov N.A., Chesnokov V.V. Portosystemic shunting procedures for complicated portal hypertension: modern opportunities of mini-invasive technique. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery. 2021; 26 (3): 34–45. http://doi.org/10.16931/1995-5464.2020127-37 (In Russian)
2. Manukyan G.V., Shertsinger A.G. Differentiated surgical treatment of portal hypertension and its complications in patients with liver cirrhosis: Part I. Assessment of diseases severity and choice of surgical intervention. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery. 2015; 2 (1): 14–23. http://doi.org/1016931/1995-5464.2018476-85 (In Russian)
3. Zatevakhin I.I., Shipovskii V.N., Tsitsiashvili M.Sh., Monakhov D.V. Portal’naya gipertenziya: diagnostika i lechenie [Portal hypertension: diagnosis and treatment]. Practical guidelines. Moscow: BukiVedi Publ., 2015. 328 p. (In Russian)
4. Kanagawa H., Mima S., Kouyama H., Gotoh K., Uchida T., Okuda K. Treatment of gastric fundal varices by balloonoccluded retrograde transvenous obliteration. J. Gastroenterol. Hepatol. 1996; 11 (1): 51–58. http://doi.org/10.1111/j.1440-1746.1996.tb00010.x
5. Chicamori F., Shibuya S., Takase Y., Ozaki A., Fukao K. Transjugular retrograde obliteration for gastric varices. Abdom. Imaging. 1996; 21 (4): 299–303. http://doi.org/10.1007/s002619900068
6. Saad W.E. Vascular anatomy and the morphologic and hemodynamic classifications of gastric varices and spontaneous portosystemic shunts relevant to the BRTO procedure. Tech. Vasc. Interv. Radiol. 2013; 16 (2): 60–100. http://doi.org/10.1053/j.tvir.2013.02.002
7. Saad W.E., Kitanosono T., Koizumi J., Hirota S. The conventional balloon-occluded retrograde transvenous obliteration procedure: indications, contraindications, and technical applications. Tech. Vasc. Interv. Radiol. 2013; 16 (2): 101–151. http://doi.org/10.1053/j.tvir.2013.02.003
8. Hiraga N., Aikata H., Takaki S., Kodama H., Shirakawa H., Imamura M., Kawakami Y., Takahashi S., Toyota N., Ito K., Tanaka S., Kitamoto M., Chayama K. The long-term outcome of patients with bleeding gastric varices after balloon-occluded retrograde transvenous obliteration. J. Gastroent. 2007; 42 (8): 663–672. http://doi.org/10.1007/s00535-007-2077-1
9. Saad W.E., Darcy M.D. Transjugular intrahepatic portosystemic shunt (TIPS) versus balloon-occluded retrograde transvenous obliteration (BRTO) for the management of gastric varices. Semin. Intervent. Radiol. 2011; 28 (3): 339–349. http://doi.org/10.1055/s-0031-1284461
10. Paleti S., Venkat Nutalapati V., Fathallah J., Jeepalyam S., Rustagi T. Balloon-occluded retrograde transvenous obliteration (BRTO) versus transjugular intrahepatic portosystemic shunt (TIPS) for treatment of gastric varices because of portal hypertension: a systematic review and metaanalysis. J. Clin. Gastroenterol. 2020; 54 (7): 655–660. http://doi.org/10.1097/MCG.0000000000001275
11. Duffy D.M. Sclerosants: a comparative review. Dermatol. Surg. 2010; 36 Suppl 2: 1010–1025. http://doi.org/10.1111/j.1524-4725.2009.01469.x
12. Kiyosue H., Mori H., Matsumoto S., Yamada Y., Hori Y., Okino Y. Transcatheter obliteration of gastric varices: Part 2. Strategy and techniques based on hemodynamic features. Radiographics. 2003; 23 (4): 921–937; discussion 937. http://doi.org/10.1148/rg.234025135
13. Hashizume M., Kitano S., Yamaga H., Sugimachi K. Haptoglobin to protect against renal damage from ethanolamine oleate sclerosant. Lancet. 1986; 2 (8606): 340–341. http://doi.org/10.1016/s0140-6736(88)92400-2.
14. Saad W.E., Sabri S.S. Balloon-occluded retrograde transvenous obliteration (BRTO): technical results and outcomes. Semin. Intervent. Radiol. 2011; 28 (3): 333–338. http://doi.org/10.1055/s-0031-1284460
15. Prajapati R., Ranjan P., Gupta A., Yadav A.K. Balloon-occluded retrograde transvenous obliteration (BRTO): a novel method of control of bleeding from post-glue ulcer over gastric varices. Report of two cases and review of literature. J. Clin. Exp. Hepatol. 2016; 6 (4): 326–330. http://doi.org/10.1016/j.jceh.2016.08.005
16. Clements W., Barrett R., Roberts S.K., Majeed A., Kemp W., Moriarty H.K. Balloon-occluded retrograde transvenous obliteration (BRTO) of gastric varices using foam sclerosant and a reduced balloon inflation time: feasibility and efficacy. J. Med. Imaging Radiat. Oncol. 2020; 64 (4): 490–495. http://doi.org/10.1111/1754-9485.13049
17. McAree B., Ikponmwosa A., Brockbank K., Abbott C., HomerVanniasinkam S., Gough M.J. Comparative stability of sodium tetradecyl sulphate (STD) and polidocanol foam: impact on vein damage in an in-vitro model. Eur. J. Vasc. Endovasc. Surg. 2012; 43 (6): 721–725. http://doi.org/10.1016/j.ejvs.2012.02.026
Supplementary files
Review
For citations:
Manukyan G.V., Malov S.L., Musin R.A., Zhigalova S.B., Lebezev V.M., Kitsenko E.A., Fandeyev E.E. First experience of balloon-occluded retrograde transvenous obliterationof gastric varices. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery. 2022;27(2):58-65. (In Russ.) https://doi.org/10.16931/1995-5464.2022-2-58-64
Views:
1432
Email this article 